Skip to main content

Eurofins Acquires Labo Van Poucke in Belgium

NEW YORK (360Dx) – Eurofins Scientific today announced the acquisition of Belgian clinical lab Labo Van Poucke.

Labo Van Poucke, or LVP, is a family-owned lab company that performs testing for hematology, serology, chemistry, immunology, microbiology and molecular biology. The acquisition of LVP will give Paris-based Eurofins Scientific an entry platform into the clinical testing market in Belgium, as well as a license to operate and sell in that market, Eurofins CEO Gilles Martin said in a statement.

LVP is licensed by the Belgian Scientific Institute of Public Health, or WIV-ISP, for clinical pathology testing, as well as by the Belgian Federal Agency for Nuclear Control, or FANC, for isotopic tests. It has been accredited by the Belgian Accreditation Body, BELAC, since 1997, and operates in compliance with the ISO 15189 standard for medical laboratories. LVP employs 34 staff and generated about €5 million ($6.2 million) in revenues in 2017.

LVP will join Eurofins Scientific's portfolio of businesses including the LifeCodexx and Genoma clinical genetics capabilities, acquired in 2017, the company's noninvasive prenatal testing, and its Biomnis portfolio of clinical diagnostics solutions, acquired in 2015.